Cyclisation strategies for stabilising peptides with irregular conformations
Literature Information
Quynh Ngoc Vu, Reginald Young, Haritha Krishna Sudhakar, Tianyi Gao, Tiancheng Huang, Yaw Sing Tan, Yu Heng Lau
Cyclisation is a common synthetic strategy for enhancing the therapeutic potential of peptide-based molecules. While there are extensive studies on peptide cyclisation for reinforcing regular secondary structures such as α-helices and β-sheets, there are remarkably few reports of cyclising peptides which adopt irregular conformations in their bioactive target-bound state. In this review, we highlight examples where cyclisation techniques have been successful in stabilising irregular conformations, then discuss how the design of cyclic constraints for irregularly structured peptides can be informed by existing β-strand stabilisation approaches, new computational design techniques, and structural principles extracted from cyclic peptide library screening hits. Through this analysis, we demonstrate how existing peptide cyclisation techniques can be adapted to address the synthetic design challenge of stabilising irregularly structured binding motifs.
Related Literature
Paper-based biodetection using luminescent nanoparticles
M. Omair Noor, Ulrich J. Krull
DOI: 10.1039/C6AN00129G
Adaptive use of a personal glucose meter (PGM) for acute biotoxicity assessment based on the glucose consumption of microbes
Yuan Yu, Jie Shen, Jinfang Zhi
DOI: 10.1039/C5AN02478A
A one-step colorimetric acid–base titration sensor using a complementary color changing coordination system
Hui Hun Cho, Si Hyun Kim, Jun Hyuk Heo, Young Eel Moon, Young Hun Choi, Dong Cheol Lim, Kwon-Hoon Han
DOI: 10.1039/C6AN00744A
The origin of the band at around 730 cm−1 in the SERS spectra of bacteria: a stable isotope approach
Patrick Kubryk, Reinhard Niessner, Natalia P. Ivleva
DOI: 10.1039/C6AN00306K
Real-time monitoring of calcification process by Sporosarcina pasteurii biofilm
Dustin Harris, Jyothir Ganesh Ummadi, Andrew R. Thurber, Yvan Allau, Circe Verba, Frederick Colwell, Marta E. Torres, Dipankar Koley
DOI: 10.1039/C6AN00007J
Correction: Micropatterning neuronal networks
Heike Hardelauf‡, Sarah Waide‡, Julia Sisnaiske, Peter Jacob, Vanessa Hausherr, Nicole Schöbel, Dirk Janasek, Christoph van Thriel
DOI: 10.1039/C6AN90037B
Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies
Jennifer Wild, Meera Shanmuganathan, Mika Hayashi, Murray Potter
DOI: 10.1039/C9AN01642B
An in vivo quantitative Raman-pH sensor of arterial blood based on laser trapping of erythrocytes
Manman Lin, Bin Xu, Huilu Yao, Aiguo Shen, Jiming Hu
DOI: 10.1039/C5AN02315G
Attenuated total reflection Fourier-transform infrared spectral discrimination in human bodily fluids of oesophageal transformation to adenocarcinoma
Ishaan Maitra, Camilo L. M. Morais, Katherine M. Ashton, Ravindra S. Date, Francis L. Martin
DOI: 10.1039/C9AN01749F
Emerging paper microfluidic devices
Bingbing Gao, Xin Li, Yaqiong Yang, Jianlin Chu, Bingfang He
DOI: 10.1039/C9AN01275C
You might also like
How should waste containing 6-Chloro-5-(2'-hydroxy-3'-methoxy-4-biphenylyl)-3-(3-methoxyphenyl)-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione (CAS: 1346607-05-3) be handled?
Waste containing 6-Chloro-5-(2'-hydroxy-3'-methoxy-4-biphenylyl)-3-(3-methoxyphe...
What are the main uses of (3alpha,5alpha)-3-Hydroxypregnane-11,20-dione (CAS: 23930-19-0)?
(3alpha,5alpha)-3-Hydroxypregnane-11,20-dione is primarily used in the pharmaceu...
What is the market or research trend for 4-Amino-6-chloro-2-pyridinecarboxylic acid (CAS: 546141-56-4)?
The market for 4-Amino-6-chloro-2-pyridinecarboxylic acid (CAS: 546141-56-4) is ...
Are there alternatives to (2-Benzoylethyl)trimethylammonium chloride (CAS: 24472-88-6) in synthesis?
Alternatives to (2-Benzoylethyl)trimethylammonium chloride (CAS: 24472-88-6) in ...
Is N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide (CAS: 393-12-4) safe?
N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide (CAS: 393-12-4) is generally safe...
Are there alternatives to [(4R,5R,6S)-5-hydroxy-10-imino-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-4-yl]methyl dihydrogen phosphate (CAS: 39679-56-6) in synthesis?
Alternative reagents such as other phosphates or similar functional groups can b...
Are there alternatives to N,N'-Bis(3-aminopropyl)-1,3-propanediamine (CAS: 4605-14-5) in synthesis?
There are alternatives to N,N'-Bis(3-aminopropyl)-1,3-propanediamine (CAS: 4605-...
What precautions should be taken when handling Aluminium trihexadecanoate (CAS: 555-35-1)?
When handling Aluminium trihexadecanoate, it is important to use appropriate per...
What is (1,1-Dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetic acid (CAS: 52188-11-1)?
(1,1-Dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetic acid is a chemical compound ...
Are there alternatives to 5,5-dimethyloxolan-2-one (CAS: 3123-97-5) in synthesis?
Several alternatives to 5,5-dimethyloxolan-2-one (CAS: 3123-97-5) can be used in...











![2-morpholino-2-[2-(trifluoromethyl)pyrimidin-5-yl]ethanamine structure 2-morpholino-2-[2-(trifluoromethyl)pyrimidin-5-yl]ethanamine structure](https://static.chemtradehub.com/structs/119/1192570-20-9-2810.webp)


-1,2-cyclohexanediamine structure N,N'-Bis[3-(2-methoxyphenyl)-2-hydroxybenzyl](1R,2R)-1,2-cyclohexanediamine structure](https://static.chemtradehub.com/structs/928/928769-12-4-a4f0.webp)
